McKesson Corporation (MCK) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped MCK stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: McKesson Corporation has strong growth potential, supported by its leadership in pharmaceutical distribution and its strategic initiatives in digital health and sustainability. Despite facing challenges such as lawsuits and supply chain issues, the company's solid fundamentals and positive industry outlook suggest above-market returns over medium-to-long-term timeframes. The saved 1-year distribution is P10 $680, P50 $850, and P90 $1,000.
Last analyzed · Model: gpt-4o
McKesson Corporation Forecast data
| Estimate | 1-year price | Meaning |
| P10 | $680 | Pessimistic plausible scenario |
| P50 | $850 | Median scenario |
| P90 | $1,000 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
McKesson Corporation is in a good position for growth given its recent acquisition and telehealth initiatives. However, supply chain issues and legal disputes create downside risks.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this MCK analysis generated?
May 7, 2026.
Is this a guaranteed MCK prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full MCK stock analysis · MCK sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.